Literature DB >> 7601470

Cloning and mapping of the mouse alpha 7-neuronal nicotinic acetylcholine receptor.

A Orr-Urtreger1, M F Seldin, A Baldini, A L Beaudet.   

Abstract

We report the isolation of cDNA clones for the mouse alpha 7 neuronal nicotinic acetylcholine receptor subunit (gene symbol Acra7), the only nicotinic receptor subunit known to bind alpha-bungarotoxin in mammalian brain. This gene may have relevance to nicotine sensitivity and to some electrophysiologic findings in schizophrenia. The mouse alpha 7 subunit gene encodes a protein of 502 amino acids with substantial identity to the rat (99.6%), human (92.8%), and chicken (87.5%) amino acid sequences. The alpha 7 gene was mapped to mouse chromosome 7 near the p locus with the following gene order from proximal to distal: Myod1-3.5 +/- 1.7 cM-Gas2-0.9 cM +/- 0.9 cM-D7Mit70-1.8 +/- 1.2 cM-Acra7-4.4 +/- 1.0 cM-Hras1-ps1/Igf1r/Snrp2a. The human gene was confirmed to map to the homologous region of human chromosome 15q13-q14.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7601470     DOI: 10.1016/0888-7543(95)80228-e

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus.

Authors:  R Freedman; H Coon; M Myles-Worsley; A Orr-Urtreger; A Olincy; A Davis; M Polymeropoulos; J Holik; J Hopkins; M Hoff; J Rosenthal; M C Waldo; F Reimherr; P Wender; J Yaw; D A Young; C R Breese; C Adams; D Patterson; L E Adler; L Kruglyak; S Leonard; W Byerley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Comparison of alpha2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice.

Authors:  Katsuyoshi Ishii; Jamie K Wong; Katumi Sumikawa
Journal:  J Comp Neurol       Date:  2005-12-12       Impact factor: 3.215

3.  Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.

Authors:  Caterina M Hernandez; Rakez Kayed; Hui Zheng; J David Sweatt; Kelly T Dineley
Journal:  J Neurosci       Date:  2010-02-17       Impact factor: 6.167

4.  In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia.

Authors:  John P Redrobe; Morten Jørgensen; Claus T Christoffersen; Liliana P Montezinho; Jesper F Bastlund; Martin Carnerup; Christoffer Bundgaard; Linda Lerdrup; Niels Plath
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

5.  Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.

Authors:  Kristin M Wildeboer; Karen E Stevens
Journal:  Brain Res       Date:  2008-06-11       Impact factor: 3.252

6.  Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.

Authors:  A Orr-Urtreger; F M Göldner; M Saeki; I Lorenzo; L Goldberg; M De Biasi; J A Dani; J W Patrick; A L Beaudet
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

Review 7.  Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Authors:  Han Xie; Natesh Yepuri; Qinghe Meng; Ravi Dhawan; Colin A Leech; Oleg G Chepurny; George G Holz; Robert N Cooney
Journal:  Rev Endocr Metab Disord       Date:  2020-08-26       Impact factor: 6.514

8.  Research tool: Validation of floxed α7 nicotinic acetylcholine receptor conditional knockout mice using in vitro and in vivo approaches.

Authors:  Caterina M Hernandez; Ibdanelo Cortez; Zhenglin Gu; José O Colón-Sáez; Patricia W Lamb; Maki Wakamiya; Jerrel L Yakel; Kelly T Dineley
Journal:  J Physiol       Date:  2014-05-30       Impact factor: 5.182

Review 9.  Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders.

Authors:  Munir Gunes Kutlu; Thomas J Gould
Journal:  Biochem Pharmacol       Date:  2015-07-29       Impact factor: 5.858

10.  Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism.

Authors:  Kristin M Wildeboer; Lijun Zheng; Kevin S Choo; Karen E Stevens
Journal:  Brain Res       Date:  2009-09-01       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.